World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201607001703323
Date of registration: 01/07/2016
Prospective Registration: No
Primary sponsor: Fedral Teaching Hospital,Abakiliki
Public title: Pentazocine versus combined Pentazocine and Diclofenac for Pain Relief in the First 24 Hours after Caesarean Section: A Randomized Controlled Study.
Scientific title: Pentazocine versus combined Pentazocine and Diclofenac for Pain Relief in the First 24 Hours after Caesarean Section: A Randomized Controlled Study.
Date of first enrolment: 01/11/2014
Target sample size: 126
Recruitment status: Complete
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=1703
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomisation using a radomisation table created by a computer software program ,Sealed opaque envelopes  
Phase:  Not Applicable
Countries of recruitment
Nigeria
Contacts
Name: Leonard    Ajah
Address:  Department of Obstetrics and Gynaecology, Faculty of Medical Sciences,University of Nigeria,Enugu Campus. 40001 Enugu Nigeria
Telephone: +2348033920789
Email: leookpanku@yahoo.com
Affiliation:  Lecturer/Honorary Consultant
Name: Leonard    Ajah
Address:  Department of Obstetrics and Gynaecology, Faculty of Medical Sciences,University of Nigeria,Enugu Campus. 40001 Enugu Nigeria
Telephone: +2348033920789
Email: leookpanku@yahoo.com
Affiliation:  Lecturer/Honorary Consultant
Key inclusion & exclusion criteria
Inclusion criteria: consenting low risk parturients who had either elective or emergency caesarean section
Had spinal anaesthesia
Conscious

Exclusion criteria: Had general anaesthesia
Had stillbirth
History of allergy to pentazocine or diclofenac.
History of severe obstetric haemorrhage Delirium
Preexisting opioid dependency
Sickle cell haemoglobinopathy
Peptic ulcer disease
Psychiatric illness
Illiteracy and
Declined consent to participate in the study despite adequate counselling.


Age minimum: 18 Year(s)
Age maximum: 49 Year(s)
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy and Childbirth

Pregnancy and Childbirth
Post-Caesarean section analgesia
Post-Caesarean section analgesia
Intervention(s)
Pentazocine plus diclofenac
Pentazocine plus sterile water for injection
Primary Outcome(s)
Postoperative pain control
Secondary Outcome(s)
patient satisfaction and maternal and neonatal adverse outcomes.
Secondary ID(s)
Source(s) of Monetary Support
Fedral Teaching Hospital,Abakilik
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 15/10/2014
Contact:
Research Ethics Committee,Federal Teaching Hospital,Abakliki
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history